Clinical validity of MR based program for analysis of fluid/brain index of posterior cranial fossa structures in patients with spinocerebellar ataxia

Polish Journal of Radiology

Volumn 73, Issue 1, 2008, Pages 32-39

  Bogusławska, Romana ^a   Rakowicz, Maria ^b   Rola, Rafał ^b   Sawicka, Beata ^b   Krawczyk, Renata ^b   Makulec, Artur ^c   Zdzienicka, Elzbieta ^b   Poniatowska, Renata ^b   Ryterski, Jarosław ^b   Sułek, Anna ^b   Walecki, Jerzy ^d   Lechowicz, Waldemar ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c SYNEKTIK Spz oo   (Poland)

^d MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

MR volumetric measurements; Spinocerebellar ataxia SCA1; Spinocerebellar ataxia SCA2

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CALCULATION; CEREBELLUM VERMIS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMISPHERE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; POSTERIOR FOSSA; SPINOCEREBELLAR DEGENERATION; VALIDATION PROCESS; VOLUMETRY; VOLUNTEER;

EID: 41149124879     PISSN: 1733134X     EISSN: 18990967     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Harding A.E.: Clinical features and classification of inherited ataxias. Adv. Neurol. 1993, 61, 1-14.
2. Klockgether T, Skalej M., Wedekind D, Luft A., Welte D, Schulz J, Abele M., Burk K., Laccone F, Brice A., Dichgans J. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain, Sep 1998; 121: 1687-1693.
3. Everett C., Wood N. Trinucleotide repeats and neurodegenerative disease. Brain, Nov 2004; 127: 2385-2405.
4. Brusco A., Gellera C., Cagnoli C., Saluto A., Castucci A., Michielotto C., Fetoni V, Mariotti C., Migone N., Di Donato S., Taroni F. Molecular Genetics of Hereditary Spinocerebellar Ataxia: Mutation Analysis of Spinocerebellar Ataxia Genes and CAG/CTG Repeat Expansion Detection in 225 Italian Families. Arch Neurol, May 2004; 61: 727-733.
5. Rüb U., Del Turco D., Del Tredici K., de Vos R.A., Brunt E., Reifenberger G., Seifried C., Schultz C., Auburger G., Braak H. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain, Oct 2003; 126: 2257-2272.
6. Trouillas P, Takayanagi T., Hallett M., Currier R.D., Subramony S.H. at al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuro-pharmacology Committee of the World Federation of Neurology, J.Neurol Sci 1997,145: 205-211.
7. Brice A.: Autosomal dominant cerebellar ataxia. Teching Courses of the ENS, Eur Neurol Soc. 2004, 26-33.
8. Stevanin G., Dürr A., Bryce A.: Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet. 2000, 8, 4-18.
9. Rakowicz M., Zdzienicka E., Poniatowska R., Waliniowska E., Sułek A., Jakubowska T., Niedzielska K., Rola R., Wierzbicka A., Hoffman-Zacharska D., Głazowski Cz., Jakubczyk T., Niewiadomska M., Zaremba J. Ataksja rdzeniowo-móżdżkowa typu 1 i 2 - porównanie oceny klinicznej, elektrofizjologicznej i rezonansu magnetycznego (Type 1 and 2 spinocerebellar ataxia - comparison of clinical assessment, electrophysiological examination and magnetic resonance - in Polish). Neurol. Neurochir. Pol. 2005, 39, 4, 263-275.
10. Dueans D. Molecular pathogenesis of spinocerebellar ataxias. Brain, 2006; 129: 1357-1370.
11. Naganka U., Suzuki Y, Kawanami T. et al.: Regional differences in genetic subgroup frequency in hereditary cerebellar ataxia, and a morphometrical study of brain MR images in SCIA1 and MJD and SCA6. J Neural Sci, 1999, 164: 187-194.
12. Villanueva-Haba V., Garces-Sanchez M., Bataller L., Palau E, Vilchez J. Neuroimaging study with morphometric analysis of hereditary and idiopathic ataxia. Neurology, Mar 2001; 16(3): 105-11.
13. Brenneis C., Bosch S., Schocke M., Wenning G., Poewe W Atrophy pattern in SCA2 determined by voxel-based worphometry. Neuroreport, Oct 2003; 14(14): 1799-802.
14. Bang O.Y., Huh K., Lee PH., Kim H.J.: Clinical and Neuroradiological Features of Patients with Spinocerebellar Ataxias from Korean Kindreds. Arch. Neurol, 2003, 60: 1566-1574.
15. Guerrini L., Lolli F, Ginestroni A., Belli G., Della Nave R., Tessa C., Foresti S., Cosottini M., Piacentini S., Salvi F, Plasmati R., De Grandis D., Siciliano G., Filla A., Mascalchi M. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain, Aug 2004; 127: 1785-1795.
16. Della Nave R., Foresti S., Tessa C., Moretti M., Ginestroni A. et al.: ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias, Neuroirnage 2004, 22: 698-705.
17. Richter S., Dimitrova A., Maschke M., Gizewski E., Beck A., Aurich V, Timmann D,: Degree of Cerebellar Ataxia Correlates with three-Dimensional MRI-Based Cerebellar Volume in Pure Cerebellar Degeneration. Eur Neurol 2005, 54: 23-27.
18. Ying S., Choi S., Perlman S., Baloh R., Zee D., Toga A. Pontine and cerebellar atrophy correlate with clinical disability in SCA2. Neurology, Feb 2006; 66: 424-426.